Review article · 2026
Targeted degradation of BRD4 by PROTACs: advances in cancer therapy
Chemical Communications, 62(17), 4869–4888 · Published 3 March 2026 · DOI 10.1039/d5cc05563f
In brief
“Targeted degradation of BRD4 by PROTACs: advances in cancer therapy” is a 2026 review article by Yanyun Hong and 6 co-authors, published in Chemical Communications. OpenAlex counts 5 citations as of 19 November 2026, which puts it in the top 3% of works published in 2026 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 5
- Most cited in
- 2026 (5)
- Field-weighted impact
- 2.47
- References
- 133
- Authors
- 7
Abstract
the ubiquitin-proteasome system (UPS). This review systematically summarizes developments over the past decade in BRD4-targeting PROTACs for cancer therapy, focusing on ternary complex design optimization, bioorthogonal activation strategies, and innovations in delivery systems. PROTACs facilitate BRD4 ubiquitination and degradation by simultaneously recruiting BRD4 and various E3 ligases, including CRBN, VHL, MDM2, and DCAF. By integrating… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Hong, Y., Liu, X., Li, Y., Yu, M., Wang, C., Nie, C., & Xu, S. (2026). Targeted degradation of BRD4 by PROTACs: advances in cancer therapy. Chemical Communications, 62(17), 4869–4888. https://doi.org/10.1039/d5cc05563f
MLA 9
Hong, Yanyun, et al. “Targeted degradation of BRD4 by PROTACs: advances in cancer therapy.” Chemical Communications, vol. 62, no. 17, 2026, pp. 4869–4888. https://doi.org/10.1039/d5cc05563f.
Chicago
Hong, Yanyun, Xiang Liu, Yanfang Li, Mengting Yu, Caolin Wang, Cunpeng Nie, and Shan Xu. 2026. “Targeted degradation of BRD4 by PROTACs: advances in cancer therapy.” Chemical Communications 62 (17): 4869–4888. https://doi.org/10.1039/d5cc05563f.
Harvard
Hong, Y. et al. (2026) ‘Targeted degradation of BRD4 by PROTACs: advances in cancer therapy’, Chemical Communications, 62(17), pp. 4869–4888. doi:10.1039/d5cc05563f.
IEEE
Y. Hong et al., “Targeted degradation of BRD4 by PROTACs: advances in cancer therapy,” Chemical Communications, vol. 62, no. 17, pp. 4869–4888, 2026, doi: 10.1039/d5cc05563f.
BibTeX
@article{hong2026targeted,
title = {{Targeted degradation of BRD4 by PROTACs: advances in cancer therapy}},
author = {Hong, Yanyun and Liu, Xiang and Li, Yanfang and Yu, Mengting and Wang, Caolin and Nie, Cunpeng and Xu, Shan},
journal = {Chemical Communications},
year = {2026},
volume = {62},
number = {17},
pages = {4869--4888},
doi = {10.1039/d5cc05563f},
url = {https://doi.org/10.1039/d5cc05563f}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- BRD4
- PROTACs
- targeted protein degradation
- ubiquitin-proteasome system
- E3 ubiquitin ligase
- cereblon
- VHL
- MDM2
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Hong, Y., Liu, X., Li, Y., Yu, M., Wang, C., Nie, C., & Xu, S. (2026). Targeted degradation of BRD4 by PROTACs: advances in cancer therapy. Chemical Communications, 62(17), 4869–4888. https://doi.org/10.1039/d5cc05563f
How many times has this paper been cited?
5 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Yanyun Hong, Xiang Liu, Yanfang Li, Mengting Yu, Caolin Wang, Cunpeng Nie, Shan Xu.
What is the DOI of this paper?
10.1039/d5cc05563f, permanently at https://doi.org/10.1039/d5cc05563f. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.